These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29613885)

  • 21. Hormone Therapy and Other Treatments for Symptoms of Menopause.
    Hill DA; Crider M; Hill SR
    Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroid growth and medical options for treatment.
    Chabbert-Buffet N; Esber N; Bouchard P
    Fertil Steril; 2014 Sep; 102(3):630-9. PubMed ID: 25171950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new approach to menopausal therapy: the tissue selective estrogen complex.
    Komm BS
    Reprod Sci; 2008 Dec; 15(10):984-92. PubMed ID: 19088368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma.
    Ohara N
    Clin Exp Obstet Gynecol; 2005; 32(1):9-11. PubMed ID: 15864926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of a standardized isopropanolic black cohosh (Actaea racemosa) extract in treatment of uterine fibroids in comparison with tibolone among patients with menopausal symptoms.
    Ross SM
    Holist Nurs Pract; 2014; 28(6):386-91. PubMed ID: 25314113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on medical treatment of uterine fibroids.
    Faustino F; Martinho M; Reis J; Águas F
    Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():61-68. PubMed ID: 28732252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EMAS position statement: management of uterine fibroids.
    Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
    Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-hormonal mediators of uterine fibroid growth.
    Cetin E; Al-Hendy A; Ciebiera M
    Curr Opin Obstet Gynecol; 2020 Oct; 32(5):361-370. PubMed ID: 32739973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy for menopausal women.
    Moghissi KS
    Compr Ther; 2000; 26(3):197-202. PubMed ID: 10984825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective estrogen modulators in menopause.
    Gambacciani M
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ulipristal acetate for uterine fibroid-related symptoms.
    Puchar A; Luton D; Koskas M
    Drugs Today (Barc); 2015 Nov; 51(11):661-7. PubMed ID: 26744741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M; Lewiecki EM
    Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexes.
    Smith CL; Santen RJ; Komm B; Mirkin S
    Breast Cancer Res; 2014 Jun; 16(3):212. PubMed ID: 25928299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances help understand and improve the safety of menopausal therapies.
    Mirkin S; Archer DF; Pickar JH; Komm BS
    Menopause; 2015 Mar; 22(3):351-60. PubMed ID: 25051290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M
    Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract]   [Full Text] [Related]  

  • 37. [Menopause and hormone replacement therapy].
    Tóth KS
    Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and evolving approaches to individualizing estrogen receptor-based therapy for menopausal women.
    Santen RJ; Kagan R; Altomare CJ; Komm B; Mirkin S; Taylor HS
    J Clin Endocrinol Metab; 2014 Mar; 99(3):733-47. PubMed ID: 24423357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GnRH analogues in the treatment of uterine fibroids.
    Golan A
    Hum Reprod; 1996 Nov; 11 Suppl 3():33-41. PubMed ID: 9147100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.